Shares of Nanosphere (NSPH +28.1%) pop after the firm announces FDA clearance for its BC-S test...


Shares of Nanosphere (NSPH +28.1%) pop after the firm announces FDA clearance for its BC-S test that can help rapidly identify bloodstream infections. The firm says the test was submitted to the FDA as the first phase of an extended process to obtain clearance for a larger test panel.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs